Are you over 18 and want to see adult content?
More Annotations
Scheersalon - Dé Scheerwinkel van Nederland en België
Are you over 18 and want to see adult content?
A complete backup of naturessunshine.com
Are you over 18 and want to see adult content?
Wein-Comedy Ingo Konrads - die komischen Seiten der Weinwelt
Are you over 18 and want to see adult content?
Best Cheap Car Insurance Quotes - CheapInsurance.com
Are you over 18 and want to see adult content?
OpenEMIS – Better data. Better education.
Are you over 18 and want to see adult content?
Planeación Docente CBTis 21
Are you over 18 and want to see adult content?
Wixon Jewelers | Luxury Jewelry Store in Minneapolis, MN
Are you over 18 and want to see adult content?
Favourite Annotations
A complete backup of https://paybyphone.fr
Are you over 18 and want to see adult content?
A complete backup of https://ticino.com
Are you over 18 and want to see adult content?
A complete backup of https://krishnafurniture.com
Are you over 18 and want to see adult content?
A complete backup of https://infyseo.com
Are you over 18 and want to see adult content?
A complete backup of https://gdgoenkanoida.edu.in
Are you over 18 and want to see adult content?
A complete backup of https://fuzzyrescue.org
Are you over 18 and want to see adult content?
A complete backup of https://inclusion.com
Are you over 18 and want to see adult content?
A complete backup of https://ravenshawuniversity.ac.in
Are you over 18 and want to see adult content?
A complete backup of https://rucaptcha.com
Are you over 18 and want to see adult content?
Text
ABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. PAIEMENT AMENDE EN LIGNE MAROC Operation Family Caregiver, Turkish Airlines Covid Test Requirements, Accident Prince George Today, The Lamb Conclusion, That Boss Life, City Of Nanaimo Payroll, Lausd Address And Phone Number, Casa Italia Liverpool, New Forest Wildlife Park Voucher, Brett Leonard Halo,ABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. PAIEMENT AMENDE EN LIGNE MAROC Operation Family Caregiver, Turkish Airlines Covid Test Requirements, Accident Prince George Today, The Lamb Conclusion, That Boss Life, City Of Nanaimo Payroll, Lausd Address And Phone Number, Casa Italia Liverpool, New Forest Wildlife Park Voucher, Brett Leonard Halo, NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement MPX BIOCEUTICAL CORPORATION PROVIDES UPDATE ON … TORONTO, ONTARIO, December 19, 2017 – (CSE:MPX, OTC:MPXEF) MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE: MPX, OTC:CMPXEF) is pleased to provide this corporate update concerning its previously announced brokered private placement (the “Placement”) of units (the “Units”), each Unit consisting of one common share and one-half of one common share purchase warrant, for MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT OFFERING OF TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MPX APPOINTS NEW CHIEF FINANCIAL OFFICER TORONTO, ONTARIO, January 16, 2018 – MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce the appointment of David McLaren as the Company’s new Chief Financial Officer, effective January 15, 2018, subject to regulatoryapproval.
MPX SIGNS A LETTER OF INTENT TO ACQUIRE CANADIAN … TORONTO, ONTARIO, April 17, 2018 – MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX, OTC: MPXEF) is pleased to announce that it has signed a letter of intent (the “LOI”) to acquire 100% of the issued and outstanding shares (the “Canveda Shares”) of Canveda Inc. (“Canveda”), a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes MPX SIGNS DEFINITIVE AGREEMENT TO EXPAND ITS FOOTPRINT IN TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the Company, through its wholly-owned U.S. subsidiary CGX Life Sciences Inc. (“CGX”), has entered into a definitive limited liability membership interest and asset purchase agreement, dated and effective March 1, 2018 to, acquire 3 CANADIAN COMPANIES ARE MAKING BIG US CANNABIS It raised C$34.2m selling shares at C$0.624 in April. Bottom line: Those who want to invest in publicly-traded multistate direct cannabis companies now have several options, with three new ones, Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences, joining Terra Tech over the past year. CANADA ‘LOST HEADSTART’ IN CANNABIS MARKET: CANADIAN Scott Boyes, CEO of Canadian Bioceutical, joins BNN to talk about delisting from the TSX Venture exchange in favour of the Canadian Securities Exchange. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE AND SIX Management Discussion and Analysis For the three and six months ended September 30, 2017 The following Management’s Discussion and Analysis (“MD&A”) of financial condition and results of operations dated November 27, 2017 relates to the unaudited interim condensed consolidated financial statements for the three and MDA DEC 31 2016 FINAL ð vshflilf ixqfwlrqv zloo doorz rxu frpsdq\ wr jdlq lpsruwdqw pdunhw vkduh 7khvh surgxfwv zloo eh lqwurgxfhg lq hduo\ 4 ri fdohqgdu ,q 1ryhpehu wkh &rusrudwlrq dqqrxqfhg wkdw zlwkABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MY ACCOUNT TELEKOM PLATA FACTURA Jack Of Hearts, Vegetarian Actors In Sandalwood, Eastenders Ben And Callum, Real Time With Bill Maher Youtube, To Kill A Mockingbird Movie Cast, My Best Friend's Girl Online Subtitrat, These Are My People, Joker Song Danse, Helen Rosenthal Apartment, At Swords Point Meaning,ABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MY ACCOUNT TELEKOM PLATA FACTURA Jack Of Hearts, Vegetarian Actors In Sandalwood, Eastenders Ben And Callum, Real Time With Bill Maher Youtube, To Kill A Mockingbird Movie Cast, My Best Friend's Girl Online Subtitrat, These Are My People, Joker Song Danse, Helen Rosenthal Apartment, At Swords Point Meaning, NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management AgreementIN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. MPX BIOCEUTICAL CORPORATION PROVIDES UPDATE ON … TORONTO, ONTARIO, December 19, 2017 – (CSE:MPX, OTC:MPXEF) MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE: MPX, OTC:CMPXEF) is pleased to provide this corporate update concerning its previously announced brokered private placement (the “Placement”) of units (the “Units”), each Unit consisting of one common share and one-half of one common share purchase warrant, for MPX SIGNS A LETTER OF INTENT TO ACQUIRE CANADIAN … TORONTO, ONTARIO, April 17, 2018 – MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX, OTC: MPXEF) is pleased to announce that it has signed a letter of intent (the “LOI”) to acquire 100% of the issued and outstanding shares (the “Canveda Shares”) of Canveda Inc. (“Canveda”), a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT OFFERING OF TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MPX SIGNS DEFINITIVE AGREEMENT TO EXPAND ITS FOOTPRINT IN TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the Company, through its wholly-owned U.S. subsidiary CGX Life Sciences Inc. (“CGX”), has entered into a definitive limited liability membership interest and asset purchase agreement, dated and effective March 1, 2018 to, acquire 3 CANADIAN COMPANIES ARE MAKING BIG US CANNABIS It raised C$34.2m selling shares at C$0.624 in April. Bottom line: Those who want to invest in publicly-traded multistate direct cannabis companies now have several options, with three new ones, Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences, joining Terra Tech over the past year. CANADA ‘LOST HEADSTART’ IN CANNABIS MARKET: CANADIAN Scott Boyes, CEO of Canadian Bioceutical, joins BNN to talk about delisting from the TSX Venture exchange in favour of the Canadian Securities Exchange. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE AND SIX Management Discussion and Analysis For the three and six months ended September 30, 2017 The following Management’s Discussion and Analysis (“MD&A”) of financial condition and results of operations dated November 27, 2017 relates to the unaudited interim condensed consolidated financial statements for the three and MDA DEC 31 2016 FINAL ð vshflilf ixqfwlrqv zloo doorz rxu frpsdq\ wr jdlq lpsruwdqw pdunhw vkduh 7khvh surgxfwv zloo eh lqwurgxfhg lq hduo\ 4 ri fdohqgdu ,q 1ryhpehu wkh &rusrudwlrq dqqrxqfhg wkdw zlwkABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MY ACCOUNT TELEKOM PLATA FACTURA Jack Of Hearts, Vegetarian Actors In Sandalwood, Eastenders Ben And Callum, Real Time With Bill Maher Youtube, To Kill A Mockingbird Movie Cast, My Best Friend's Girl Online Subtitrat, These Are My People, Joker Song Danse, Helen Rosenthal Apartment, At Swords Point Meaning,ABOUT OVERVIEW
Overview. MPX Bioceutical Corporation’s mission is to become a leading commercial producer of medical marijuana and pharma-grade products in North America. We are committed to providing patients with consistent high quality, efficacious cannabis and other natural products while providing shareholders with an attractive rate ofreturn on
INVESTORS – MPX BIOCEUTICAL CORP Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim. MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018. NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management Agreement CONTACT – MPX BIOCEUTICAL CORP MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US.CURRENT OPENINGS
MPX is a fast-growing company that offers a wide range of opportunities. We’re committed to having a positive impact in the communities we operate in, ensuring a safe workplace, and providing our employees with gold-standard training.ABOUT PARTNERS
Health For Life. MPX Bioceutical operates two Health For Life dispensaries in the Greater Phoenix Area, and is developing a third, expected to be fully operational by the end of Q2/2018. Staffed by a helpful, knowledgeable team, H4L dispensaries are committed to serving the needs of the medical marijuana community in Arizona.IN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. A VERTICALLY INTEGRATED MULTI- STATE CANNABIS THE U.S. CANNABIS MARKET people in states with legalized medical cannabis >200 million registered card holders 1 >2.3 million people instates with
MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT … TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MY ACCOUNT TELEKOM PLATA FACTURA Jack Of Hearts, Vegetarian Actors In Sandalwood, Eastenders Ben And Callum, Real Time With Bill Maher Youtube, To Kill A Mockingbird Movie Cast, My Best Friend's Girl Online Subtitrat, These Are My People, Joker Song Danse, Helen Rosenthal Apartment, At Swords Point Meaning, NEWS – MPX BIOCEUTICAL CORP MPX Enters Into Management & Purchase Option Agreements With LMS Wellness, Benefit LLC in Baltimore MarylandMPX to Complete Dispensary Buildout and Provide Operational Support Through An Exclusive Management AgreementIN THE MEDIA
MPX Bioceutical Corporation’s mission is to become a leading commercial producer of pharma-grade medical and recreational cannabis products in Canada and the US. MPX BIOCEUTICAL CORPORATION PROVIDES UPDATE ON … TORONTO, ONTARIO, December 19, 2017 – (CSE:MPX, OTC:MPXEF) MPX Bioceutical Corp. (the “Company” or “MPX”) (CSE: MPX, OTC:CMPXEF) is pleased to provide this corporate update concerning its previously announced brokered private placement (the “Placement”) of units (the “Units”), each Unit consisting of one common share and one-half of one common share purchase warrant, for MPX SIGNS A LETTER OF INTENT TO ACQUIRE CANADIAN … TORONTO, ONTARIO, April 17, 2018 – MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE: MPX, OTC: MPXEF) is pleased to announce that it has signed a letter of intent (the “LOI”) to acquire 100% of the issued and outstanding shares (the “Canveda Shares”) of Canveda Inc. (“Canveda”), a Licensed Producer under Health Canada’s Access to Cannabis for Medical Purposes MPX CLOSES OVERSUBSCRIBED PRIVATE PLACEMENT OFFERING OF TORONTO, ONTARIO, December 22, 2017 – (CSE: MPX, OTC:MPXEF) MPX Bioceutical Corporation (the “Company” or “MPX”) (CSE: MPX, OTC:MPXEF) is pleased to announce that it has successfully closed its previously announced private placement offering (the “Offering”) of units (the “Units”) of the Company. MPX SIGNS DEFINITIVE AGREEMENT TO EXPAND ITS FOOTPRINT IN TORONTO, March 05, 2018 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (“MPX” or the “Company”) (CSE:MPX) (OTC:MPXEF) is pleased to announce that the Company, through its wholly-owned U.S. subsidiary CGX Life Sciences Inc. (“CGX”), has entered into a definitive limited liability membership interest and asset purchase agreement, dated and effective March 1, 2018 to, acquire 3 CANADIAN COMPANIES ARE MAKING BIG US CANNABIS It raised C$34.2m selling shares at C$0.624 in April. Bottom line: Those who want to invest in publicly-traded multistate direct cannabis companies now have several options, with three new ones, Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences, joining Terra Tech over the past year. CANADA ‘LOST HEADSTART’ IN CANNABIS MARKET: CANADIAN Scott Boyes, CEO of Canadian Bioceutical, joins BNN to talk about delisting from the TSX Venture exchange in favour of the Canadian Securities Exchange. MANAGEMENT DISCUSSION AND ANALYSIS FOR THE THREE AND SIX Management Discussion and Analysis For the three and six months ended September 30, 2017 The following Management’s Discussion and Analysis (“MD&A”) of financial condition and results of operations dated November 27, 2017 relates to the unaudited interim condensed consolidated financial statements for the three and MDA DEC 31 2016 FINAL ð vshflilf ixqfwlrqv zloo doorz rxu frpsdq\ wr jdlq lpsruwdqw pdunhw vkduh 7khvh surgxfwv zloo eh lqwurgxfhg lq hduo\ 4 ri fdohqgdu ,q 1ryhpehu wkh &rusrudwlrq dqqrxqfhg wkdw zlwk* HOME
* CULTIVATION
* EXTRACTION + FORMULATIONS* PRODUCTS
* RETAIL
* OUR BUSINESS
* OUR STORY
* MANAGEMENT
* BOARD OF DIRECTORS* ADVISORY BOARD
* GLOBAL FOOTPRINT
* OUR BRANDS
* MEDIA
* NEWSLETTER
* Newsletter Jan. 15/2020* Newsletter Signup
* CONTACT
* CORPORATE HQ
* EUROPEAN OFFICE
* INVESTORS
* NEWS / EVENTS
* COMPANY INFO
* STOCK DATA
* GOVERNANCE
* SEDAR
* MENU
A NEXT GENERATION
CANNABIS COMPANY
CULTIVATION
Through years of developing cultivation facilities, we’re able to apply our expertise across various continents and cultivate in a variety of formats, from highly-automated indoor grows to multi-hectare outdoor farms. Our cultivation operations are fully diversified to serve both regulated medical markets and rapidly evolving consumer markets, and we’re positioned for the long run with a strong focus on cost-competitiveness. STATE-OF-THE-ART INDOOR CERTIFIED ORGANIC SUN-GROWN EXTRACTION + FORMULATIONS We’ve continued to live up to the MPX reputation for best-in-class cannabis concentrates and extracts. Our proprietary SOPs have been developed to highly sophisticated US standards and are being implemented into our GMP medical production facilities and Swiss extraction laboratory. We utilize high-capacity supercritical C02, as well as ethanol extraction processes, coupled with cutting-edge distillation and formulation equipment. PHARMA-GRADE PROCESSES INNOVATIVE PRODUCT FORMULATIONS AWARD-WINNING PRODUCTS With over 90 medical SKUs and 60 consumer and wellness SKUs, our diverse portfolio of products caters to a wide range of patients and consumers. We actively formulate using 9 different cannabinoids and take pride in ensuring product quality is consistent from market tomarket.
MEDICAL
CONSUMER
PIONEERING RETAIL EXPERIENCES Whether as a showcase for our brands or an outlet for 3rd party brands, we aim to set the bar high in new markets. Through education and engaging retail experiences, we are giving consumers a look into the exciting world of new cannabis and cannabinoid innovations.BELEAF STORES
HOLYWEED STORES
LATEST NEWS
MPXI Announces South Africa Cultivation Joint Venture in Wine Region MPXI Receives LOI from Malta Enterprise and Acquires GMP-Ready Pharmaceutical Manufacturing Facility HolyWeed Granted Belgium Import Authorization for Cannabis LightProducts
CORPORATE HQ
5255 Yonge Street, Suite 701Toronto, Ontario
M2N 6P4
Canada
info@mpxinternationalcorp.com+1 (416) 840-3725
EUROPEAN OFFICE
6 Ganton St,
London
W1F 7QW
United Kingdom
info@mpxinternationalcorp.com+44 (0) 7495-775510
2019 Copyright - MPX International Corporation Scroll to topDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0